AQR Capital Management »

Century Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $36k 21k 1.71

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Century Therapeutics

VR Adviser
Boxer Capital
Casdin Capital
BlackRock
DAFNA Capital Management
Geode Capital Management
Tang Capital Management
Baker Bros. Advisors
Octagon Capital Advisors
Renaissance Technologies
Charles Schwab Investment Management
Northern Trust
Acadian Asset Management
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding Century Therapeutics